QUOTE
Questions for debate:
1.)What policies should the U.S. push for to best prepare for a bird flu outbreak?
Bush is spending billions to make us ready when a flu pandemic hits.
http://www.whitehouse.gov/news/releases/20...01jpg-515h.htmlQUOTE
2.)Do you believe our elected leaders have done enough to protect us from bird flu or other virus outbreaks? Pleae provide evidence to support your contention
THIS virus is not a threat to humans in general. What we need, and it is in the works, are ways to make vaccines quickly when a flu virus appears. Now it takes 6 months.
STATES have responsibility as well and some will do better than others.
http://www.nctimes.com/articles/2006/12/21..._1415_15_06.txtThe world is several billion doses short of the flu vaccine production capacity needed to guard against a possible global influenza pandemic, the World Health Organization warned on Monday.
The WHO has now launched an emergency plan aimed at expanding industry's ability to produce seasonal vaccines from the current 350 million doses per year to levels that might be required to protect the whole of the world's population – about 6.7 billion people, officials said.
Governments need to invest $3 billion to $10 billion dollars in the coming years to close the gap between potential vaccine demand and supply during a pandemic, they say (see Stockpile human bird flu vaccine now say experts).
http://www.newscientist.com/channel/health...roduction-.htmlhttp://www.npr.org/templates/story/story.php?storyId=5036908Race to find new vaccine production techniques in fight against influenzaWill vaccines from hens' eggs eventually be a thing of the past? Novel methods of vaccine production like cell culture technology and DNA vaccines are set to revolutionise prophylaxis against viral diseases such as influenza. Jenny Bryan investigates
http://www.pjonline.com/Editorial/20051029..._influenza.htmlNew Strategy Speeds Flu Vaccine Production Cell-based approach means shots could be made in weeks, not months
By Robert Preidt
THURSDAY, Feb. 16 (HealthDay News) -- Researchers say they've developed a commercially viable process that could enable the mass production of flu vaccines within weeks, instead of the months it now takes.
This approach uses a purified protein from the surface of a virus called hemagglutinin (the "H" in a virus' designation -- for example -- the H5N1 bird flu virus) to trigger an immune response to a specific strain of virus.
The genes responsible for production of hemagglutinin are inserted into a pathogen called a baculovirus, which are then used to infect specific host cells. Those infected cells produce recombinant hemagglutinin (rHA).
Phase II clinical trials show that the vaccines produced using this method are safe and trigger an immune response equal to or greater than conventional chicken egg-based vaccines.
http://www.hon.ch/News/HSN/531050.htmlhttp://www.medicalnewstoday.com/medicalnews.php?newsid=52770